Skip to content
10-Q

Quarterly Report

Eledon Pharmaceuticals, Inc. ELDN

0001193125-25-283275

← back to feed
Filed
Nov 14, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 7, 2025 59.93M sh
Shares Diluted Q3 2025 · Sep 30, 2025 77.16M sh
Shares Diluted Q3 2025 · Sep 30, 2025 77.15M sh
Shares Diluted Q3 2025 · Sep 30, 2024 55.48M sh
Shares Diluted Q3 2025 · Sep 30, 2024 43.11M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$48.25M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$28.28M
Short Term Investments Q3 2025 · Sep 30, 2025 $89.73M
Short Term Investments Q3 2025 · Dec 31, 2024 $119.63M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $3.67M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $20.55M
Stockholders Equity Q3 2025 · Sep 30, 2025 $35.36M
Stockholders Equity Q3 2025 · Jun 30, 2025 $50.33M
Stockholders Equity Q3 2025 · Mar 31, 2025 $58.89M
Stockholders Equity Q3 2025 · Dec 31, 2024 $62.45M
Stockholders Equity restated Q3 2025 · Sep 30, 2024 $20.36M
Stockholders Equity restated Q3 2025 · Jun 30, 2024 −$64.2M
Stockholders Equity restated Q3 2025 · Mar 31, 2024 −$70.42M
Stockholders Equity restated Q3 2025 · Dec 31, 2023 −$48.49M
Current Liabilities Q3 2025 · Sep 30, 2025 $14.3M
Current Liabilities Q3 2025 · Dec 31, 2024 $11.58M
Total Liabilities Q3 2025 · Sep 30, 2025 $38.8M
Total Liabilities Q3 2025 · Dec 31, 2024 $59.27M
Current Assets Q3 2025 · Sep 30, 2025 $96.3M
Current Assets Q3 2025 · Dec 31, 2024 $143.73M
Total Assets Q3 2025 · Sep 30, 2025 $129.86M
Total Assets Q3 2025 · Dec 31, 2024 $177.41M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.21
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.42
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$0.28
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$1.23
Eps Basic Q3 2025 · Sep 30, 2025 −$0.21
Eps Basic Q3 2025 · Sep 30, 2025 −$0.42
Eps Basic Q3 2025 · Sep 30, 2024 $1.05
Eps Basic Q3 2025 · Sep 30, 2024 $0.13
Sga Expense Q3 2025 · Sep 30, 2025 $4.1M
Sga Expense Q3 2025 · Sep 30, 2025 $12.99M
Sga Expense Q3 2025 · Sep 30, 2024 $3.99M
Sga Expense Q3 2025 · Sep 30, 2024 $11.85M
Rd Expense Q3 2025 · Sep 30, 2025 $14.97M
Rd Expense Q3 2025 · Sep 30, 2025 $48.78M
Rd Expense Q3 2025 · Sep 30, 2024 $16.52M
Rd Expense Q3 2025 · Sep 30, 2024 $34.04M
Net Income Q3 2025 · Sep 30, 2025 −$17.46M
Net Income Q3 2025 · Sep 30, 2025 −$35.17M
Net Income Q3 2025 · Jun 30, 2025 −$11.22M
Net Income Q3 2025 · Mar 31, 2025 −$6.5M
Net Income Q3 2025 · Sep 30, 2024 $76.97M
Net Income Q3 2025 · Sep 30, 2024 $8.43M
Net Income Q3 2025 · Jun 30, 2024 −$44.91M
Net Income Q3 2025 · Mar 31, 2024 −$23.63M
Operating Income Q3 2025 · Sep 30, 2025 −$19.07M
Operating Income Q3 2025 · Sep 30, 2025 −$61.77M
Operating Income Q3 2025 · Sep 30, 2024 −$20.51M
Operating Income Q3 2025 · Sep 30, 2024 −$45.88M